Neonatal Systemic lupus erythematosus: Clinical Trials

6 trials for Neonatal Systemic lupus erythematosus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 unknown. 1 Early Phase 1, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Early Phase 11Completed 1
Not applicable1Completed 1
Phase 21Completed 1

Follow Neonatal Systemic lupus erythematosus: new trials by email Literature Review of Neonatal Systemic lupus erythematosus trials Research Report on Neonatal Systemic lupus erythematosus

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fetal-Hope Study: Home Monitoring of Fetal Heart Rate in SSA+ Pregnant Women
Pregnancy Related, Autoimmune Diseases
UnknownASST Fatebenefratelli Sacco2002022-04-142023-07-24
Prospective Maternal Surveillance of SSA (Sjögren Syndrome A) Positive Pregnancies Using a Hand-held Fetal Heart Rate Monitor
Sjogren's Syndrome, Neonatal Systemic Lupus Erythematosus
CompletedUniversity of Colorado, Denver7002014-03-012021-06-23
Preventive Approach to Congenital Heart Block With Hydroxychloroquine
Hydroxychloroquine - Congenital Heart Block, Neonatal Lupus
Phase 2CompletedNYU Langone Health742011-01-012021-02-25
The Research Registry for Neonatal Lupus
No intervention; observational - Neonatal Lupus, Systemic Lupus Erythematosus
CompletedNYU Langone Health1002010-05-272023-08-03
Preventive IVIG Therapy for Congenital Heart Block
intravenous immune globulin (IVIG) - Congenital Heart Block, Neonatal Lupus
Early Phase 1CompletedNYU Langone Health202007-04-012019-09-30
Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus
Dexamethasone or other corticosteroid - Congenital Heart Block, Neonatal Lupus
Not applicableCompletedNYU Langone Health1502000-10-012016-03-11

Narrower conditions

Sjogren's Syndrome (5)  ·  Congenital heart block (4)  ·  Autoimmune Diseases (3)  ·  Lupus Erythematosus, Systemic (3)

Broader conditions

Arthritis (5)  ·  Arthritis, Rheumatoid (5)  ·  Connective Tissue Diseases (5)  ·  Dry Eye Syndromes (5)  ·  Eye Diseases (5)  ·  Immune System Diseases (5)  ·  Joint Diseases (5)  ·  Lacrimal Apparatus Diseases (5)  ·  Mouth Diseases (5)  ·  Musculoskeletal Diseases (5)  ·  Rheumatic Diseases (5)  ·  Salivary Gland Diseases (5)  ·  Skin and Connective Tissue Diseases (5)  ·  Stomatognathic Diseases (5)  ·  Xerostomia (5)

Interventions

Dexamethasone (1)  ·  Hydroxychloroquine (1)  ·  Immunoglobulins, Intravenous (1)

Sponsors

NYU Langone Health (4)  ·  ASST Fatebenefratelli Sacco (1)  ·  University of Colorado, Denver (1)

Countries

United States (5)  ·  Italy (1)

Top investigators

Jill P. Buyon, MD (2)  ·  Antonio Luca Brucato, Prof (1)  ·  Bettina F Cuneo, MD (1)  ·  Jill P Buyon, MD (1)  ·  Jill P. Buyon (1)

Results publications

PMID 18195175, PMID 30309472, PMID 11180122, PMID 11508435, PMID 12765470, PMID 15368347, PMID 16980725, PMID 20391423, PMID 20538173, PMID 20696016, PMID 21602492, PMID 21969015, PMID 22626746, PMID 22832822, PMID 24268009, PMID 25440767, PMID 25980596, PMID 28843719, PMID 28899797, PMID 30137589, PMID 30620419, PMID 30784137, PMID 30873413, PMID 31685414, PMID 32674792, PMID 32806663, PMID 32907357, PMID 33556767, PMID 35014577

NIH funding

R01AR046265 (1)